BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11775127)

  • 1. Association of beta2-adrenoceptor Gln27Glu variant with body weight but not hypertension.
    Lin RCY ; Ericsson JO; Benjafield AV; Morris BJ
    Am J Hypertens; 2001 Dec; 14(12):1201-4. PubMed ID: 11775127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.
    Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2006 Oct; 19(10):1084-91. PubMed ID: 17027833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism.
    Macho-Azcárate T; Calabuig J; Martí A; Martínez JA
    J Physiol Biochem; 2002 Jun; 58(2):103-8. PubMed ID: 12435085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, Type II diabetes and the beta 2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population.
    Duarte NL; Colagiuri S; Palu T; Wang XL; Wilcken DE
    Clin Sci (Lond); 2003 Mar; 104(3):211-5. PubMed ID: 12605574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain.
    González Sánchez JL; Proenza AM; Martínez Larrad MT; Ramis JM; Fernández Pérez C; Palou A; Serrano Ríos M
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):476-81. PubMed ID: 14510910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population.
    Meirhaeghe A; Helbecque N; Cottel D; Amouyel P
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):382-7. PubMed ID: 10757635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between a human beta-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesity.
    Kortner B; Wolf A; Wendt D; Beisiegel U; Evans D
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1099-100. PubMed ID: 10557032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women.
    Kunnas T; Lahtio R; Kortelainen ML; Kalela A; Nikkari ST
    Lipids Health Dis; 2009 Oct; 8():43. PubMed ID: 19832974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
    Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
    Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism.
    Martínez JA; Corbalán MS; Sánchez-Villegas A; Forga L; Marti A; Martínez-González MA
    J Nutr; 2003 Aug; 133(8):2549-54. PubMed ID: 12888635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor β2 surface gene on obesity and metabolic phenotypes in Taiwan.
    Hsiao TJ; Lin E
    J Investig Med; 2014 Feb; 62(2):310-5. PubMed ID: 24322328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.
    Xie HG; Stein CM; Kim RB; Gainer JV; Sofowora G; Dishy V; Brown NJ; Goree RE; Haines JL; Wood AJ
    Clin Pharmacol Ther; 2000 Jun; 67(6):670-5. PubMed ID: 10872649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss intervention.
    Szendrei B; González-Lamuño D; Amigo T; Wang G; Pitsiladis Y; Benito PJ; Gomez-Candela C; Calderón FJ; Cupeiro R;
    Appl Physiol Nutr Metab; 2016 Mar; 41(3):307-14. PubMed ID: 26888112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gln27Glu polymorphism in β2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis.
    Daghestani MH; Warsy A; Daghestani MH; Al-odaib AN; Eldali A; Al-Eisa NA; Al-zhrani S
    Lipids Health Dis; 2010 Aug; 9():90. PubMed ID: 20738880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men.
    Mori Y; Kim-Motoyama H; Ito Y; Katakura T; Yasuda K; Ishiyama-Shigemoto S; Yamada K; Akanuma Y; Ohashi Y; Kimura S; Yazaki Y; Kadowaki T
    Biochem Biophys Res Commun; 1999 Apr; 258(1):138-40. PubMed ID: 10222249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes.
    Bengtsson K; Orho-Melander M; Melander O; Lindblad U; Ranstam J; Råstam L; Groop L
    Hypertension; 2001 May; 37(5):1303-8. PubMed ID: 11358945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
    Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.